Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • FingerMotion signed a binding LOI to buy ~20.2 acres in Hanna, Alberta for a second campus under its 99 MW Alberta program.
  • The site offers 3 MW grid power plus natural gas interconnection for behind-the-meter generation.
  • Planned powered campus capacity is 9.9 MW targeting AI and HPC clients.
  • FingerMotion will secure permits, power, and client contracts before committing to construction.
  • Development and construction will be handled by BlueFlare Group Holdings.
  • The move expands FingerMotion's AI/HPC footprint and supports demand for regional data center capacity in Alberta.

Latest Articles

NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License
Jul 27, 2026
Avery Klein
Press Releases

NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License

PMGC Holdings Inc., via its subsidiary NorthStrive Defense Tech, has engaged Deploy360 to conduct an independent technical validation of a patented GPS-denied autonomous navigation technology for drones. This validation, using Deploy360's AI-driven testing platform, aims to assess the software, architecture, and performance under simulated conditio…

ELAB
Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer
Jul 27, 2026
Avery Klein
Press Releases

Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer

Eikon Therapeutics announced the dosing of the first patient in its TeLuRide-008 Phase 2/3 trial evaluating EIK1001 combined with pembrolizumab and chemotherapy in treatment-naïve, stage 4 Non-Small Cell Lung Cancer (NSCLC). This trial aims to improve outcomes in NSCLC patients by enhancing immune response through a novel dual Toll-like receptor ag…

EIKN
US Defense Manufacturer, Elmet Technologies, to Streamline Supply Chain for Rapid Production of Hypersonic Vehicle Parts with 3D Systems DMP Flex 350 Triple
Jul 27, 2026
Hana Yamamoto
Press Releases

US Defense Manufacturer, Elmet Technologies, to Streamline Supply Chain for Rapid Production of Hypersonic Vehicle Parts with 3D Systems DMP Flex 350 Triple

Elmet Technologies, a US-based defense manufacturer and subsidiary of The Elmet Group (Nasdaq: ELMT), is deploying 3D Systems' DMP Flex 350 Triple metal additive manufacturing system to rapidly produce advanced aerospace parts for hypersonic vehicles. Leveraging a high-performance C103 alloy developed with 3D Systems' Application Innovation Group, …

ELMT
Frequency Electronics Inc. Announces Space Mission Contract Award Valued at Approximately $8 million
Jul 27, 2026
Sofia Navarro
Press Releases

Frequency Electronics Inc. Announces Space Mission Contract Award Valued at Approximately $8 million

Frequency Electronics, Inc. has been awarded a follow-on production contract valued at approximately $8 million to supply compact, precise atomic clocks for position, navigation, and timing in lunar space missions. This contract demonstrates the company's strong position in space technology and a rapid expansion in its space exploration business, i…

FEIM
QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP
Jul 27, 2026
Marcus Reed
Press Releases

QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP

QTREX Quantum Ltd. announced a research collaboration with Northeastern University focused on developing advanced micro-system structures for cryogenic quantum interconnects. The partnership gives QTREX first negotiation rights for commercialization of IP generated from the joint research. This initiative aims to enhance QTREX's quantum connectivit…

QTEX
Quantum Cyber Completes First Mini-Interceptor Drone at Its Newly U.S. Manufacturing Facility in Bridgeport, Connecticut
Jul 27, 2026
Derek Hwang
Press Releases

Quantum Cyber Completes First Mini-Interceptor Drone at Its Newly U.S. Manufacturing Facility in Bridgeport, Connecticut

Quantum Cyber announced that its subsidiary, Quantum Drones Corporation, has completed manufacturing its first mini-interceptor drone at its new 50,000 sq. ft. U.S. manufacturing facility in Bridgeport, Connecticut. This marks a strategic shift from technology development to vertically integrated production of autonomous defense drones. The mini-in…

QUCY
Indonesia Energy Corporation Commences Drilling of K-29 Well
Jul 27, 2026
Jordan Park
Press Releases

Indonesia Energy Corporation Commences Drilling of K-29 Well

Indonesia Energy Corporation (NYSE American: INDO) announced the commencement of drilling operations at its K-29 well located in the Kruh Block on Sumatra island. The well has a planned depth of 3,400 feet and marks the first of two wells scheduled for drilling in 2026. Preparations for drilling at the WK-5 site are underway, continuing the company…

INDO
Ponce Financial Group, Inc. Reports Second Quarter 2026 Results
Jul 27, 2026
Avery Klein
Press Releases

Ponce Financial Group, Inc. Reports Second Quarter 2026 Results

Ponce Financial Group, Inc. (Nasdaq: PDLB), the holding company for Ponce Bank, announced its second quarter 2026 financial results, highlighting increased net income, net interest income, and loan growth compared to prior periods. The bank continues to maintain strong capital ratios and is on track to potentially repurchase preferred stock under a…

PDLB
Lula Maintains Edge Over Bolsonaro in BTG/Nexus Poll Ahead of October Runoff
Jul 27, 2026
Sofia Navarro
World

Lula Maintains Edge Over Bolsonaro in BTG/Nexus Poll Ahead of October Runoff

A Nexus poll commissioned by BTG Pactual indicates President Luiz Inacio Lula da Silva leads Senator Flavio Bolsonaro in a hypothetical second-round vote for Brazil's October presidential election, and also tops a multi-candidate first-round scenario. The survey of 2,004 people conducted July 24-26 reports a 47% to 43% margin in the simulated runof…

HBT Financial, Inc. Announces Second Quarter 2026 Financial Results
Jul 27, 2026
Leila Farooq
Press Releases

HBT Financial, Inc. Announces Second Quarter 2026 Financial Results

HBT Financial, Inc. announced robust second quarter 2026 financial results reflecting the successful acquisition and integration of CNB Bank Shares, Inc. The company reported a net income of $27.8 million, up significantly from prior periods, with improved returns on assets and equity. Net interest income and margins increased due to higher loan yi…

HBT
IMF Chief Visits Buenos Aires as Argentina Faces a Heavy 2027 Debt Load
Jul 27, 2026
Marcus Reed
Economy

IMF Chief Visits Buenos Aires as Argentina Faces a Heavy 2027 Debt Load

IMF Managing Director Kristalina Georgieva makes her first visit to Argentina amid growing investor confidence in President Javier Milei's reform agenda. Economic indicators such as rising exports, growing foreign-exchange reserves and sharply lower inflation have lifted sentiment, and credit rating agencies have issued upgrades. Still, a $32.3 bil…

Americold and Feed the Children Celebrate 10 Years of Helping Families Access Food and Essential Resources
Jul 27, 2026
Jordan Park
Press Releases

Americold and Feed the Children Celebrate 10 Years of Helping Families Access Food and Essential Resources

Americold celebrates 10 years of collaboration with Feed the Children, contributing over $2.4 million and leveraging its temperature-controlled logistics to provide more than 2.1 million pounds of food and resources to over 2.7 million individuals nationwide. The partnership embodies Americold's commitment to community support and sustainability wi…

COLD
Lakeland Financial Reports Record Second Quarter Performance; Net Income Increases 5% to $28.4 million on 7% Revenue Expansion; Average Loans Grow by 6%
Jul 27, 2026
Avery Klein
Press Releases

Lakeland Financial Reports Record Second Quarter Performance; Net Income Increases 5% to $28.4 million on 7% Revenue Expansion; Average Loans Grow by 6%

Lakeland Financial Corporation reported a record second quarter 2026 net income of $28.4 million, a 5% increase year-over-year, driven by 7% growth in total revenue and 6% growth in average loans. The company maintained a stable net interest margin of 3.49%, improved capital ratios, expanded its loan portfolio across commercial and consumer segment…

LKFN
Picard Medical Receives NYSE American Acceptance of Compliance Plan
Jul 27, 2026
Sofia Navarro
Press Releases

Picard Medical Receives NYSE American Acceptance of Compliance Plan

Picard Medical, the only US-based maker of the FDA-approved total artificial heart, announced NYSE American has accepted its compliance plan to meet listing standards, allowing the company to continue trading under ticker PMI. The company is focusing on operational, strategic, and financial initiatives, including advancing its next-generation Emper…

PMI
VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb
Jul 27, 2026
Leila Farooq
Press Releases

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

VERAXA Biotech announced successful progression of its bispecific ADC program VXA-222 following a key milestone achieved in its collaboration with OmniAb. This program utilizes an AND-gate logic to target two antigens on solid tumors and has now moved into the next phase, combining OmniAb’s antibody discovery technology with VERAXA’s conjugation an…

VRXA
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
Jul 27, 2026
Derek Hwang
Press Releases

OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026

OKYO Pharma Limited, a clinical-stage biopharmaceutical company focused on neuropathic corneal pain and anterior segment eye diseases, announced its participation in the BTIG Biotechnology Conference 2026. Management will present virtually and offer one-on-one meetings. The company plans to initiate a global Phase 3 pivotal trial in H2 2026 for its…

OKYO
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
Jul 27, 2026
Maya Rios
Press Releases

Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026

Neumora Therapeutics announced positive results from a repeat 13-week toxicology study for its oral NLRP3 inhibitor NMRA-215, intended to treat obesity and cardiometabolic disease. Following the favorable safety profile and efficacy data, the company plans to submit an IND application and initiate clinical trials for NMRA-215 in late 2026. The drug…

NMRA